[Retracted] The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma

Figure 5

Function and somatic mutation of RPL4P4. (a and b) The involvement of genes coexpressed with RPL4P4 in glioma signaling pathways as examined by GSEA software. (c) Molecules associated with a somatic mutation describe RPL4P4 mutations in glioma. (d) Correlation between RPL4P4 and IDH1.

(a)

(b)

(c)

(d)